Abbott Laboratories and Dexcom are the biggest players in the market for continuous glucose monitoring devices. Abbott has a vast lineup of products beyond that and an overall diversified healthcare ...
This call is being recorded by Abbott. With the exception of any participant's questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is ...
Abbott Laboratories ABT0.85%increase; green up pointing triangle cut its full-year earnings outlook to account for a recent acquisition and said a weaker-than-expected flu season hurt its recent ...
April 16 (Reuters) - Abbott Laboratories (ABT.N), opens new tab won the dismissal of a proposed class action by parents who alleged its Similac infant formula contained undisclosed heavy metals. In a ...
Abbott Laboratories cut its full-year earnings outlook to account for a recent acquisition and said its nutrition unit continued to notch soft sales during the first quarter. The company, which sells ...
Abbott Laboratories (NYSE: ABT) more or less met analyst estimates in its first quarter, the results of which were published early Thursday morning. This clearly wasn't good enough for investors, as ...
Abbott Laboratories must pay $53 million in compensatory damages in four cases in which Chicago area babies developed a dangerous intestinal disease after consuming the company’s formula for premature ...
CHICAGO (WLS) -- A trial that lasted five weeks is over regarding baby formula made by Illinois-based Abbott Labs. A jury said the result is what the parents of four Illinois babies deserve after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results